Treatment for Interstitial Cystitis

Phase-Based Progress Estimates
The University of California San Diego Health, San Diego, CAInterstitial Cystitis+1 More
18 - 80
What conditions do you have?

Study Summary

This trial is testing whether a new method of testing for and treating urinary infections is more effective than the current standard.

Eligible Conditions
  • Interstitial Cystitis

Treatment Effectiveness

Study Objectives

1 Primary · 4 Secondary · Reporting Duration: 1 year

1 year
Effectiveness of PCR/NGS directed antimicrobial therapy assessed by the Global Response Assessment (GRA)
Safety of PCR/NGS directed antimicrobial therapy by measuring the incidence of Treatment-Emergent Adverse Events by the SAE questionnaire
Stratification comparison
Type of sample comparison

Trial Safety

Trial Design

0 Treatment Group

100 Total Participants · 0 Treatment Group

Primary Treatment: Treatment · No Placebo Group · N/A

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 1 year

Who is running the clinical trial?

MicroGenDXLead Sponsor
2 Previous Clinical Trials
75 Total Patients Enrolled

Eligibility Criteria

Age 18 - 80 · Female Participants · 8 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You have been experiencing symptoms continuously for at least 3 months.
You may be able to participate in the study if you experience discomfort in your bladder and/or urethra and have difficulty storing urine, but only if you meet certain requirements during the initial screening.
You have ongoing bladder pain or chronic urinary tract infection symptoms.
You have not taken any supplements for urinary tract infection (UTI) such as cranberry, d-mannose, high dose vitamin C, or Lactobacillus probiotics in the past two weeks.

Frequently Asked Questions

Are individuals currently being recruited for involvement in this experiment?

"Affirmative. The particulars of the trial, which were initially declared on February 1st 2022 and last updated March 2nd 2022, are available to view on; these details indicate that 100 subjects will be enrolled at two separate locations." - Anonymous Online Contributor

Unverified Answer

To what extent is this experiment being conducted with human participants?

"Affirmative, the data on confirms that this trial is presently enrolling patients. The study's first posting date was February 1st 2022 and it was most recently updated on March 2nd 2022. This medical investigation requires 100 participants from two distinct locations to partake in their experimentations." - Anonymous Online Contributor

Unverified Answer

Is it possible for me to enroll in this experiment?

"This clinical trial is recruiting 100 individuals suffering from bladder pain syndrome, ranging in age between 18 and 80. Notably, potential participants must abide by the following conditions: Signed informed consent that includes agreement with protocol-specified requirements and limitations; Diagnosis of BPS (NIH/NIDDK/MAPP) or CCS (modified ACSS); Previous unsuccessful antibiotic treatment based on past urine culture results; At least 3 months continuous symptoms; Average daily bladder pain score ≥3 on a 0-10 NRS scale in preceding 3 months; No antibiotics nor UTI supplements for two weeks prior to enrollment." - Anonymous Online Contributor

Unverified Answer

Does this medical experiment have an age restriction of 80 years or below?

"This clinical trial has established age parameters, with minimum enrollment being 18 years old and the maximum enrolment at 80." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.